Mostim 24Mg/1.2Ml Inj
₹29,990.00
Attributes
- Is Prescription Required
- Yes
- Is Returnable
- No
- Type
- Pharma
- Consume Type
- Parenteral
- Pack Size
- 1.2
- Cold Chain Product
- Yes
- Banned
- No
- Marketer Address
- Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.
- Pack Form
- Vial
- Product Form
- Injection
- Unit Of Measurement
- ml
- Subcategory
- Neoplastic Disorders
- Manufacturer
- CADILA HEALTHCARE LTD
- Country Of Origin
- India
- Classifier 1
- NEOPLASTIC DISORDERS
- Classifier 2
- SUPPORTIVE DRUGS
- Classifier 3
- SUPPORTIVE DRUGS
- Restricted
- Yes
- Is Sensitive
- Yes
- Dosage Forms
- Injection
- Short Name
- Mostim 24Mg/1.2Ml Inj
- Unitprice
- ₹21992.67 / 1 ml
- Dpco Drug
- No
Description
Key Benefits
Mostim 24Mg/1.2Ml Inj contains Plerixafor, which belongs to the hemopoietic stem cell mobilizer class or drugs. It works by binding to the chemokine receptor CXCR4 and inhibiting its cognate ligand CXCL12 binding. This mobilizes hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in cancer patients.
Directions for Use
Mostim 24Mg/1.2Ml Inj will be administered by a trained healthcare professional. Hence, do not self-administer.
Side Effects
-
Nausea
-
Dizziness
-
Stomach upset
-
Headache
-
Vomiting
-
Insomnia
-
Arthralgia
-
Diarrhoea
-
Pain at the site of injection
Storage
Store in a cool and dry place away from sunlight
Additional information
| Is Prescription Required | |
|---|---|
| Is Returnable | |
| Type | |
| Consume Type | |
| Pack Size | |
| Cold Chain Product | |
| Banned | |
| Marketer Address | |
| Pack Form | |
| Product Form | |
| Unit Of Measurement | |
| Subcategory | |
| Manufacturer | |
| Country Of Origin | |
| Classifier 1 | |
| Classifier 2 | |
| Classifier 3 | |
| Restricted | |
| Is Sensitive | |
| Dosage Forms | |
| Short Name | |
| Unitprice | |
| Dpco Drug |
